Systematic review of anticoagulant treatment of catheter-related thrombosis

Thrombosis Research

Volumn 136, Issue 6, 2015, Pages 1103-1109

  Baumann Kreuziger, Lisa ^a,b   Onwuemene, Oluwatoyosi ^c   Kolesar, Emma ^d   Crowther, Mark ^d   Lim, Wendy ^d  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; BLEEDING; CATHETER THROMBOSIS; CENTRAL VENOUS CATHETER; DEEP VEIN THROMBOSIS; HUMAN; LUNG EMBOLISM; POSTTHROMBOSIS SYNDROME; PRIORITY JOURNAL; RECURRENCE RISK; RISK ASSESSMENT; SYSTEMATIC REVIEW; TREATMENT DURATION; UPPER EXTREMITY DEEP VEIN THROMBOSIS;

ANTICOAGULANTS; HUMANS; UPPER EXTREMITY DEEP VEIN THROMBOSIS;

EID: 84949316352     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2015.08.020     Document Type: Article

References (38)

1. D.C. McGee, and M.K. Gould Preventing complications of central venous catheterization N. Engl. J. Med. 348 12 2003 1123 1133
2. A.Y. Lee, and P.W. Kamphuisen Epidemiology and prevention of catheter-related thrombosis in patients with cancer J. Thromb. Haemost. 10 8 2012 1491 1499
3. N. Kucher Clinical practice. Deep-vein thrombosis of the upper extremities N. Engl. J. Med. 364 9 2011 861 869
4. M. Monreal, A. Raventos, R. Lerma, and et al. Pulmonary embolism in patients with upper extremity DVT associated to venous central lines - a prospective study Thromb. Haemost. 72 4 1994 548 550
5. E.E. Elman, and S.R. Kahn The post-thrombotic syndrome after upper extremity deep venous thrombosis in adults: a systematic review Thromb. Res. 117 6 2006 609 614
6. F.J. Munoz, P. Mismetti, R. Poggio, and et al. Clinical outcome of patients with upper-extremity deep vein thrombosis: results from the RIETE registry Chest 133 1 2008 143 148
7. P. Prandoni, A.W. Lensing, A. Piccioli, and et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis Blood 100 10 2002 3484 3488
8. J.I. Zwicker, G. Connolly, M. Carrier, P.W. Kamphuisen, and A.Y. Lee Catheter-associated deep vein thrombosis of the upper extremity in cancer patients: guidance from the SSC of the ISTH J. Thromb. Haemost. 12 5 2014 796 800
9. C. Kearon, E.A. Akl, A.J. Comerota, and et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2 Suppl. 2012 e419S e494S
10. P. Debourdeau, D. Farge, M. Beckers, and et al. International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer J. Thromb. Haemost. 11 1 2013 71 80
11. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.
12. R. Chang, M.K. Horne 3rd, D.J. Mayo, and J.L. Doppman Pulse-spray treatment of subclavian and jugular venous thrombi with recombinant tissue plasminogen activator J. Vasc. Interv. Radiol. 7 6 1996 845 851
13. L.E. Flinterman, V.A. van Hylckama, F.R. Rosendaal, and C.J. Doggen Recurrent thrombosis and survival after a first venous thrombosis of the upper extremity Circulation 118 13 2008 1366 1372
14. J.R. Gould, H.W. Carloss, and W.L. Skinner Groshong catheter-associated subclavian venous thrombosis Am. J. Med. 95 4 1993 419 423
15. S.R. Kahn, E.A. Elman, C. Bornais, M. Blostein, and P.S. Wells Post-thrombotic syndrome, functional disability and quality of life after upper extremity deep venous thrombosis in adults Thromb. Haemost. 93 3 2005 499 502
16. M.J. Kovacs, S.R. Kahn, M. Rodger, and et al. A pilot study of central venous catheter survival in cancer patients using low-molecular-weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (the catheter study) J. Thromb. Haemost. 5 8 2007 1650 1653
17. A. Pucheu, M. Dierhas, B. Leduc, and et al. Fibrinolysis of deep venous thrombosis on implantable perfusion devices. Apropos of a consecutive series of 57 cases of thrombosis and 32 cases of fibrinolysis Bull. Cancer 83 4 1996 293 299
18. V.L. Schimp, A.R. Munkarah, R.T. Morris, G. Deppe, and J. Malone Jr. Upper extremity deep vein thrombosis associated with indwelling peripheral venous catheters in gynecology oncology patients Gynecol. Oncol. 89 2 2003 301 305
19. J. Schindler, R.D. Bona, H.H. Chen, and et al. Regional thrombolysis with urokinase for central venous catheter-related thrombosis in patients undergoing high-dose chemotherapy with autologous blood stem cell rescue Clin. Appl. Thromb. Hemost. 5 1 1999 25 29
20. H. Tran, M. Arellano, A. Chamsuddin, and et al. Deep venous thromboses in patients with hematological malignancies after peripherally inserted central venous catheters Leuk. Lymphoma 51 8 2010 1473 1477
21. A. Delluc, G. Le Gal, D. Scarvelis, and M. Carrier Outcome of central venous catheter associated upper extremity deep vein thrombosis in cancer patients Thromb. Res. 135 2 2015 298 302
22. R. Frizzelli, O. Tortelli, V. Di Comite, R. Ghirardi, C. Pinzi, and C. Scarduelli Deep venous thrombosis of the neck and pulmonary embolism in patients with a central venous catheter admitted to cardiac rehabilitation after cardiac surgery: a prospective study of 815 patients Intern. Emerg. Med. 3 4 2008 325 330
23. M. Monreal, F.J. Munoz, V. Rosa, and et al. Upper extremity DVT in oncological patients: analysis of risk factors. Data from the RIETE registry Exp. Oncol. 28 3 2006 245 247
24. S. Schulman, and C. Kearon Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients J. Thromb. Haemost. 3 4 2005 692 694
25. K.J. Savage, P.S. Wells, V. Schulz, and et al. Outpatient use of low molecular weight heparin (dalteparin) for the treatment of deep vein thrombosis of the upper extremity Thromb. Haemost. 82 3 1999 1008 1010
26. D. Farge, P. Debourdeau, N.C. Gorin, A. Lamblin, and F. Cajfinger Long-term efficacy and safety of low-molecular-weight heparins (LMWH) for cancer-associated venous thromboembolism (VTE) in tropique, a prospective non-interventional observational study Blood 124 21 2014 4273
27. K. Vu, N.V. Luong, J. Hubbard, and et al. A retrospective study of venous thromboembolism in acute leukemia patients treated at the University of Texas MD Anderson Cancer Center Cancer Med. 4 1 2015 27 35
28. A.F. Aburahma, D.L. Sadler, and P.A. Robinson Axillary subclavian vein thrombosis. Changing patterns of etiology, diagnostic, and therapeutic modalities Am. Surg. 57 2 1991 101 107
29. P. Gloviczki, F.J. Kazmier, and L.H. Hollier Axillary-subclavian venous occlusion: the morbidity of a nonlethal disease J. Vasc. Surg. 4 4 1986 333 337
30. E. Pintor Holguin, F. Saez Noguero, M.V. Piret Ceballos, and et al. Axillary-subclavian thrombosis: review of its etiology and features in recent years An. Med. Interna 14 2 1997 67 70
31. E. Ascher, S. Salles-Cunha, and A. Hingorani Morbidity and mortality associated with internal jugular vein thromboses Vasc. Endovasc. Surg. 39 4 2005 335 339
32. A. Hingorani, E. Ascher, N. Markevich, and et al. Risk factors for mortality in patients with upper extremity and internal jugular deep venous thrombosis J. Vasc. Surg. 41 3 2005 476 478
33. A. Hingorani, E. Ascher, E. Lorenson, and et al. Upper extremity deep venous thrombosis and its impact on morbidity and mortality rates in a hospital-based population J. Vasc. Surg. 26 5 1997 853 860
34. O. Karabay, U. Yetkin, and H. Onol Upper extremity deep vein thrombosis: clinical and treatment characteristics J. Int. Med. Res. 32 4 2004 429 435
35. P.L. Massoure, J. Constans, M. Caudry, and et al. Upper extremity deep venous thrombosis. 40 hospitalized patients J. Mal. Vasc. 25 4 2000 250 255
36. T. Enden, Y. Haig, N.E. Klow, and et al. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial Lancet 379 9810 2012 31 38
37. L. Watson, C. Broderick, and M.P. Armon Thrombolysis for acute deep vein thrombosis Cochrane Database Syst. Rev. 1 2014 CD002783
38. S.R. Kahn, A.J. Comerota, M. Cushman, and et al. The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association Circulation 130 18 2014 1636 1661